Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers

Dr. John Thachil, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Professional interests include: blood disorders, chemotherapy, brain cancer, and more.

506 Graham Drive Suite 200
Tomball, TX 77375

(832) 996-4300

Dr. John Thachil, MD is a medical oncologist in Houston, TX specializing in medical oncology, adult oncology and adult hematology. Dr. John Thachil, MD is affiliated with Houston Methodist, HCA Houston Healthcare, Texas Oncology and HCA Houston Healthcare Tomball.

Office Locations

Address:

13215 Dotson Road Suite 300
Houston, TX 77070

Address:

13300 Hargrave Road Suite 190
Houston, TX 77070

Address:

506 Graham Drive Suite 200
Tomball, TX 77375

Some issues Dr. John Thachil, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

biological response modifier (BRM) therapy	55
blood draw	288
chemotherapy	55
doctor visit	337
hospital care	336
inpatient care	336
lab tests	335
minimally invasive procedures	93

**Gender**
Male	70
Female	100

**Ethnicity**
Non-Hispanic White	95
Black	42
Hispanic	19
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	67
From 75 to 84	53
85 and over	22
Less than 65	28

biological response modifier (BRM) therapy	127
blood draw	491
chemotherapy	127
doctor visit	604
hospital care	222
inpatient care	222
lab tests	671
minimally invasive procedures	220

**Gender**
Male	73
Female	126

**Ethnicity**
Non-Hispanic White	126
Black	41
Hispanic	20
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	71
From 75 to 84	77
85 and over	24
Less than 65	27

biological response modifier (BRM) therapy	112
blood draw	405
chemotherapy	112
doctor visit	448
hospital care	227
inpatient care	227
lab tests	436
minimally invasive procedures	197

**Gender**
Male	168
Female	256

**Ethnicity**
Non-Hispanic White	278
Black	72
Hispanic	50
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	160
From 75 to 84	130
85 and over	64
Less than 65	70

biological response modifier (BRM) therapy	123
blood draw	433
chemotherapy	123
doctor visit	472
hospital care	291
inpatient care	291
lab tests	405
minimally invasive procedures	206

**Gender**
Male	103
Female	163

**Ethnicity**
Non-Hispanic White	168
Black	64
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	102
From 75 to 84	86
85 and over	32
Less than 65	46

biological response modifier (BRM) therapy	122
blood draw	346
chemotherapy	122
doctor visit	395
hospital care	289
inpatient care	289
lab tests	354
minimally invasive procedures	171

**Gender**
Male	111
Female	170

**Ethnicity**
Non-Hispanic White	171
Black	56
Hispanic	37
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	108
From 75 to 84	97
85 and over	38
Less than 65	38

biological response modifier (BRM) therapy	77
blood draw	375
chemotherapy	77
doctor visit	400
hospital care	265
inpatient care	265
lab tests	338
minimally invasive procedures	119

**Gender**
Male	94
Female	136

**Ethnicity**
Non-Hispanic White	152
Black	46
Hispanic	19
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	85
From 75 to 84	72
85 and over	41
Less than 65	32

biological response modifier (BRM) therapy	136
blood draw	108
chemotherapy	136
doctor visit	418
hormone therapy	33
hospital care	190
inpatient care	190
lab tests	419
minimally invasive procedures	209

**Gender**
Male	105
Female	161

**Ethnicity**
Non-Hispanic White	180
Black	45
Hispanic	27
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	111
From 75 to 84	75
85 and over	38
Less than 65	42

biological response modifier (BRM) therapy	187
blood draw	138
chemotherapy	187
doctor visit	419
hospital care	109
inpatient care	109
lab tests	504
minimally invasive procedures	252

**Gender**
Male	98
Female	120

**Ethnicity**
Non-Hispanic White	153
Black	30
Hispanic	19
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	93
From 75 to 84	70
85 and over	32
Less than 65	23

biological response modifier (BRM) therapy	229
blood draw	119
chemotherapy	229
doctor visit	259
hospital care	49
inpatient care	49
lab tests	324
minimally invasive procedures	324

**Gender**
Male	77
Female	141

**Ethnicity**
Non-Hispanic White	147
Black	37
Hispanic	20
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	92
From 75 to 84	76
85 and over	32
Less than 65	18

biological response modifier (BRM) therapy	191
blood draw	115
chemotherapy	191
doctor visit	315
hormone therapy	57
hospital care	127
inpatient care	127
lab tests	307
minimally invasive procedures	328
port flush	18

**Gender**
Male	117
Female	147

**Ethnicity**
Non-Hispanic White	190
Black	40
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	127
From 75 to 84	86
85 and over	31
Less than 65	20

Average Medicare Procedure Volume From 2013 - 2022

Volume of procedures performed by Dr. John Thachil, MD for Medicare patients.

The highest averages for the top procedures that Dr. John Thachil, MD treated as a medical oncologist in Houston, TX were lab tests, blood draw, minimally invasive procedures and hospital care.

biological response modifier (BRM) therapy	135
blood draw	281
chemotherapy	135
doctor visit	409
hormone therapy	45
hospital care	210
inpatient care	210
lab tests	411
minimally invasive procedures	211

Average Medicare Patient Data From 2013 - 2022

Information about Medicare patients treated by Dr. John Thachil, MD.

**Gender**
Male	101
Female	152

**Ethnicity**
Black / African American	47
Asian / Pacific Islander	0
Non-Hispanic White	166
Native American / Alaskan Native	0
Hispanic	24
Other	0

**Age**
75 to 84	82
85 and over	35
Less than 65	34
65 to 74	101

Average of Total of Conditions of Medicare patients treated by Dr. John Thachil, MD From 2013 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. John Thachil, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	75
High Cholesterol	63
Stroke	13
Ischemic Heart Disease	51
Depression	29
Chronic Kidney Disease	53
Asthma	13
Osteoporosis	12
Heart Failure	40
Chronic Obstructive Pulmonary Disease	28
Diabetes	44
Atrial Fibrillation	20
Cancer	36
Dementia	21

Education & Training

He completed residency at Advocate Illinois Masonic Medical Center. He is certified by the Hematology Internal Medicine Medical Oncology and has a state license in Texas.

Residency: Advocate Illinois Masonic Medical Center

Board Certification: Hematology Internal Medicine Medical Oncology

Licensed In: Texas

Affiliations & Hospitals

Dr. John Thachil, MD is associated with these hospitals and organizations:

Houston Methodist

HCA Houston Healthcare

Texas Oncology

HCA Houston Healthcare Tomball

Ratings & Reviews

Dr. John Thachil, MD does not have any reviews yet, be the first to leave a review of Dr. John Thachil, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. John Thachil, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$883 PROMACTA $235	TASIGNA $208	KISQALI $191	VOTRIENT $44	VOTRIENT RCC $40	Other $164
E.R. Squibb & Sons, L.L.C.	$551 OPDIVO $376	ELIQUIS $32	SPRYCEL $18	EMPLICITI $17	ERBITUX $14	Other $93
Janssen Biotech, Inc.	$548 IMBRUVICA $294	Erleada $112	DARZALEX $98	TECVAYLI $31	$13
Amgen Inc.	$547 Vectibix $181	Kyprolis $141	XGEVA $140	LUMAKRAS $59	Prolia $15	Other $11
Pfizer Inc.	$487 BOSULIF $149	IBRANCE $90	ELIQUIS $57	PREVNAR - 13 $51	OXBRYTA $45	Other $96
Other	$4,256 Venclexta $311	KEYTRUDA $237	Pomalyst $183	Gilotrif $140	CYRAMZA $134	Other $3,250

**Types of Payments**
Food and Beverage	$6,230
Education	$1,042

Research Payments

Dr. John Thachil, MD has received 8 research payments totaling $27,489.

Biography

Dr. John Thachil practices adult hematology, adult oncology, and medical oncology. His areas of expertise include the following: bladder cancer, blood cancers, and anemia. Dr. Thachil trained at Advocate Illinois Masonic Medical Center for his residency. In addition to English, he speaks Malayalam. His professional affiliations include Houston Methodist, HCA Houston Healthcare, and Texas Oncology.